Aditxt: Edison Open House Healthcare 2022

Aditxt: Edison Open House Healthcare 2022

Aditxt — 2 videos in collection

Aditxt is a life sciences company developing technologies specifically focused on improving the health of the immune system through immune reprogramming and monitoring.

• Tell us about the company’s product development strategy.
• Can you tell us about AditxtScore for COVID-19 and the information it provides that you wouldn’t get from either antigen or PCR testing?
• How has AditxtScore been received in the marketplace and which organisations are using the platform?
• Please update us on the situation around the emergency use application (EUA) for AditxtScore and how important this is for your business.
• What are some of the potential advantages of your Apoptotic DNA Immunotherapy (ADI)?
• Which milestones should investors focus on in the coming year?


You may also be interested in these:

Cookie Policy Overview
Edison Group

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping us understand which section of the website you find more interesting and useful. See our Cookie Policy for more information.

Strictly necessary and functional

These cookies are used to deliver our website and content. Strictly necessary cookies relate to our hosting environment, and functional cookies are used to facilitate social logins, social sharing and rich-media content embeds.

Advertising

Advertising Cookies collect information about your browsing habits such as the pages you visit and links you follow. These audience insights are used to make our website more relevant.

Performance

Performance Cookies collect anonymous information designed to help us improve the site and respond to the needs of our audiences. We use this information to make our site faster, more relevant and improve the navigation for all users.